Chief Executive Officer
Valdemaras Rodzko is the Managing Director and CEO of Caerus Biotech, as well as the CEO of GryNumber Health Group. A former Business Development Manager for GlaxoSmithKline in Central Europe, Valdemaras holds more than two decades of managerial experience in the field of international pharma marketing and business development. Since 2019, Valdemaras has also served as the President of the Pharmaceutical Licensing Group in Central and Eastern Europe (PLG CEE). In addition to this, Valdemaras is a qualified Medical Doctor and possesses a Master of Management.
Chief Medical Officer
Evaldas Brazaitis is a Co-Founder and the Chief Medical Officer of both Caerus Biotech and GryNumber Health. He has extensive experience in the biotechnology and medical marketing fields, having formerly served as the Head of Biotech for the healthcare business, Merck Serono, and as a Group Production Manager for GlaxoSmithKline. Evaldas is a qualified Medical Doctor and holds a Master of Management, having conducted higher studies in Sweden, Norway and Lithuania.
Chief Financial Officer
Martynas is a seasoned international financial manager and serves as Chief Financial Officer at Caerus Biotech and GryNumber Health. Prior to this, Martynas held various Finance Director roles for GlaxoSmithKline across Central and Eastern Europe. Martynas holds a Master’s Degree in Finance and a Professional Qualification from the Chartered Institute of Management Accountants (CIMA).
Chief Commercial Officer
As a Chief Commercial Officer, Martynas spearheads Caerus Biotech’s vast network of global partnerships. He has led multiple product launches and managed the fertility portfolio strategy within the GryNumber Health Group. Previously, Martynas contributed to GlaxoSmithKline’s business development initiatives in Central and Eastern Europe. A Global Business graduate from the University of Redlands in California, he has completed an additional course on EU business affairs at the University of Freiburg in Germany.
Chief Operating Officer
Building on two decades of operational expertise, Kiril serves as Caerus Biotech’s Chief Operating Officer. His track record includes international mergers and acquisitions (M&A) projects with pharma giants GlaxoSmithKline, Novartis and ViiV Healthcare; constructing international supply chains; implementing track-and-trace programmes; and managing strategic ERP and digitalisation projects.
Dominyka is a Project Specialist at Caerus Biotech, working on strategic business development and partner identification initiatives. She has previously supported GryNumber Health with special project management. Prior to this, Dominyka authored a number of academic articles on novel medical materials. Her work has featured in renowned publications like the International Journal of Environmental Research and Public Health. Dominyka is a graduate of Vilnius University, Faculty of Medicine.
Business Development Manager
Nikola serves as Caerus Biotech‘s Business Development Manager. A skilled project manager with a seven-year track record at GryNumber Health, Nikola has demonstrated his proficiency in an international pharmaceutical environment. Nikola has vast experience in compliance and regulatory affairs. He holds a Master’s degree in Management from ISM University of Management and Economics.
Logistics & Customer Service Specialist
Tomas is the Customer Service & Logistics specialist at Caerus Biotech and GryNumber Health. Previously, Tomas worked in customer service at one of the world’s leading courier and logistics companies, and, as part of the Special Services team, demonstrated his expertise in logistics, shipping and building unique transport solutions.
Join the Team
Become a part of our exciting mission to help patients navigate their fertility journey.